MHRA introduces new safeguards to strengthen antidepressant safety information following major review

MHRA announced changes to antidepressant safety information for patients, carers and healthcare professionals following a review. It says updated leaflets, a patient card and a supporting safety leaflet will make existing warnings on suicidal thoughts and behaviours and persistent sexual dysfunction clearer.

Why it matters: MHRA says the materials will support risk and benefit discussions, a topic relevant to patient communication in antidepressant research.